Atika Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-39,700	Closed	-$3.58M	–	120
2021 Q3	$3.58M	Sell	39,700 -3,300	-8%	-$298K	0.21%	97
2021 Q2	$4.1M	Sell	43,000 -23,000	-35%	-$2.4M	0.32%	83
2021 Q1	$7.51M	Sell	66,000 -23,000	-26%	-$3.13M	0.65%	64
2020 Q4	$12.3M	Buy	89,000 +10,400	+13%	+$1.23M	0.96%	46
2020 Q3	$6.46M	Sell	78,600 -400	-0.5%	-$33.2K	0.53%	63
2020 Q2	$6.18M	Buy	79,000 +40,500	+105%	+$2.68M	0.8%	53
2020 Q1	$1.71M	Buy	38,500 +33,098	+613%	+$1.72M	0.33%	71
2019 Q4	$231K	Buy	+5,402	New	+$223K	0.04%	76
2019 Q3	–	Sell	-28,000	Closed	-$1.78M	–	84
2019 Q2	$1.78M	Buy	+28,000	New	+$1.78M	0.35%	73
2015 Q3	–	Sell	-10,400	Closed	-$1.06M	–	75
2015 Q2	$1.06M	Buy	+10,400	New	+$808K	0.48%	58